Cover Image

Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice

Hypercholesterolemia is one of the independent risk factors for the development of cardiovascular diseases such as atherosclerosis. The treatment of hypercholesterolemia is of great significance to reduce clinical cardiovascular events and patient mortality. Simvastatin (SIM) and ezetimibe (EZE) are...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shamuha Bahetibieke (Author), Sakib M. Moinuddin (Author), Asiya Baiyisaiti (Author), Xiaoang Liu (Author), Jie Zhang (Author), Guomin Liu (Author), Qin Shi (Author), Ankang Peng (Author), Jun Tao (Author), Chang Di (Author), Ting Cai (Author), Rong Qi (Author)
Format:	Book
Published:	MDPI AG, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physical Stability and Viscoelastic Properties of Co-Amorphous Ezetimibe/Simvastatin System
by: Justyna Knapik-Kowalczuk, et al.
Published: (2019)

Role of Ezetimibe in Combination with Statins(Simvastatin and Atorvastatin) in Controlling Dyslipidemia
by: Falah H.Al-Malki, et al.
Published: (2017)

Role of Ezetimibe in Combination with Statins(Simvastatin and Atorvastatin) in Controlling Dyslipidemia
by: Falah H.Al-Malki, et al.
Published: (2017)

Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals-The Case of Simvastatin
by: Justyna Knapik-Kowalczuk, et al.
Published: (2020)

Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations
by: Agata Górniak, et al.
Published: (2022)

6-Gingerol Regulates Hepatic Cholesterol Metabolism by Up-regulation of LDLR and Cholesterol Efflux-Related Genes in HepG2 Cells
by: Xiao Li, et al.
Published: (2018)

Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability
by: Liu P, et al.
Published: (2020)

Hot-Melt Extruded Amorphous Solid Dispersion for Solubility, Stability, and Bioavailability Enhancement of Telmisartan
by: Bhupendra Raj Giri, et al.
Published: (2021)

LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
by: Ziye Chen, et al.
Published: (2021)

Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe
by: Jonny Kinzi, et al.
Published: (2024)

Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice
by: Zoe White, et al.
Published: (2022)

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial
by: Antonio Carlos Amedeo Vattimo, MD, MSc, et al.
Published: (2020)

Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins
by: Harold E. Bays, et al.
Published: (2021)

Simultaneous administration of fluoxetine and simvastatin ameliorates lipid profile, improves brain level of neurotransmitters, and increases bioavailability of simvastatin
by: Al-Asmari AK, et al.
Published: (2017)

Tanshinone IIA alleviates atherosclerosis in LDLR−/− mice by regulating efferocytosis of macrophages
by: Jiarou Wang, et al.
Published: (2023)

RED ROSELLA TEA AND AVOCADO AS SIMVASTATIN THERAPY SUPPORT REDUCE TOTAL CHOLESTEROL
by: Budi Artini, et al.
Published: (2017)

Efficacy of Ezetimibe/Simvastatin (10/10 mg) Versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials
by: Gaoming YANG, et al.
Published: (2019)

Simultaneous determination of ezetimibe and simvastatin in rat plasma by stable-isotope dilution LC-ESIâMS/MS and its application to a pharmacokinetic study
by: Sireesha R. Karanam, et al.
Published: (2014)

HVC1 ameliorates hyperlipidemia and inflammation in LDLR−/− mice
by: Se-Yun Cheon, et al.
Published: (2017)

How Does the Addition of Kollidon<sup>®</sup>VA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions?
by: Joanna Szafraniec-Szczęsny, et al.
Published: (2021)

Mechanisms of increased bioavailability through amorphous solid dispersions: a review
by: Andreas Schittny, et al.
Published: (2020)

Improvement in the Oral Bioavailability and Efficacy of New Ezetimibe Formulations-Comparative Study of a Solid Dispersion and Different Micellar Systems
by: Carlos Torrado-Salmerón, et al.
Published: (2020)

Mechanism of Dissolution Enhancement and Bioavailability of Poorly Water Soluble Celecoxib by Preparing Stable Amorphous Nanoparticles
by: Yinghui Liu, et al.
Published: (2010)

Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe in Pharmaceutical Formulations
by: Mathrusri Annapurna Mukthinuthalapati, et al.
Published: (2014)

Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics
by: Ahmed OA, et al.
Published: (2015)

Enhancing Oral Bioavailability of Simvastatin Using Uncoated and Polymer-Coated Solid Lipid Nanoparticles
by: Amira E. Abd-Elghany, et al.
Published: (2024)

Mechanism for Stabilizing an Amorphous Drug Using Amino Acids within Co-Amorphous Blends
by: Yannick Guinet, et al.
Published: (2023)

Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program
by: T. O. Bessonova, et al.
Published: (2023)

MONOTHERAPY EZETIMIBE-INDUCED RHABDOMYOLYSIS
by: Niharika Baviriseaty, MD
Published: (2024)

Ezetimibe and Cancer: Is There a Connection?
by: Jia Gu, et al.
Published: (2022)

Formulation and Evaluation of Ezetimibe Nanoparticles
by: bijps, et al.
Published: (2017)

Formulation and Evaluation of Ezetimibe Nanoparticles
by: Yasser A.Ali, et al.
Published: (2017)

Combining Co-Amorphous-Based Spray Drying with Inert Carriers to Achieve Improved Bioavailability and Excellent Downstream Manufacturability
by: Yingxi Zhang, et al.
Published: (2020)

The Amorphous Solid Dispersion of Chrysin in Plasdone<sup>®</sup> S630 Demonstrates Improved Oral Bioavailability and Antihyperlipidemic Performance in Rats
by: Chenhui Wang, et al.
Published: (2023)

Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability
by: Jaewook Kwon, et al.
Published: (2019)

Application of Sucrose Acetate Isobutyrate in Development of Co-Amorphous Formulations of Tacrolimus for Bioavailability Enhancement
by: Eman M. Mohamed, et al.
Published: (2023)

Stability indicating RP-UPLC method for simultaneous quantification of bempedoic acid and ezetimibe in bulk and pharmaceutical formulations
by: Uma Sai Teja Yarra, et al.
Published: (2021)

Improved solubility, dissolution rate, and oral bioavailability of main biflavonoids from Selaginella doederleinii extract by amorphous solid dispersion
by: Bing Chen, et al.
Published: (2020)

Microwave-Induced In Situ Amorphization: A New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions
by: Wei Qiang, et al.
Published: (2020)

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
by: Bożena Karolewicz, et al.
Published: (2019)